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Abstract The orientation of the catalytic site of a ganglioside-
specific sialidase in the plasma membrane of SK-N-MC
neuroblastoma cells was probed using water-soluble GD1a-
neoganglioprotein substrate on intact cells and GM1-product
detection by cholera toxin B. Desialylation of substrate was
readily observed, whereas specific sialidase inhibitors prevented
the reaction, and conditioned medium was inactive. Inhibitors of
endocytosis and acidification had no effect on substrate
degradation, and lowering temperature to 18‡C reduced activity
but did not abolish it. We conclude that the ganglioside sialidase
activity is cell surface-orientated and displays an in situ
specificity that mirrors enzyme preparations in vitro. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Gangliosides of the plasma membrane are modulators of
various cellular functions including cell adhesion, cellular in-
teractions, cell growth, di¡erentiation, and neural repair [1^3].
Control of a cell’s ganglioside lining may therefore be of pro-
found impact on cellular behavior. Such control can be based
on both biosynthetic and degradative processes. Major sites of
ganglioside metabolism are the endoplasmic reticulum and the
Golgi apparatus for biosynthetic reactions, and the lysosomal
compartment for ¢nal degradation [3]. The only known reac-
tions for in situ modelling of the cell surface ganglioside pat-
tern are that of a sialyltransferase presumably located at the
outer surface of synaptosomal membranes from calf brain [4],
and that of a ganglioside-speci¢c sialidase in neuronal calf
brain membranes [5] or in the plasma membrane of human
SK-N-MC neuroblastoma cells [6] ; the neuroblastoma cell
enzyme acted speci¢cally on gangliosides with terminal sialic
acids, yielding a shift from higher sialylated species to GM1
and a conversion of GM3 to lactosylceramide [7]. Since inhi-
bition of the enzyme by inclusion of speci¢c inhibitors in the
medium of SK-N-MC neuroblastoma cultures led to a release
from contact inhibition of growth and a loss of di¡erentiation
markers, a role of the ganglioside sialidase on growth control
and di¡erentiation in this neuronal cell line was suggested [8].
The plasma membrane sialidase of neuronal tissues was
recently puri¢ed and characterized [9,10] and has just been
cloned [11^14]. In transfected COS-7 cells a protein protection
assay suggested that the sialidase might be an atypical type I
membrane protein and it was speculated that ganglioside de-
sialylation would occur on the cytoplasmic side of the plasma
membrane or in intracellular vesicles formed by plasma mem-
brane budding [12]. In contrast, however, incubation of intact
cells in the presence of millimolar concentrations of Cu2 at
low temperature completely inactivated the plasma mem-
brane-associated sialidase activity [6], and inclusion of the
sialidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic
acid (NeuAc2en) in the culture medium totally blocked am-
monia-insensitive desialylation of plasma membrane-inserted
radiolabelled ganglioside GM3 [8], both observations pointing
to a cell surface-orientated sialidase activity. In order to fur-
ther proceed in understanding the sialidase’s cellular func-
tions, it would therefore be helpful to de¢nitely establish the
orientation of the enzyme in the plasma membrane. To this
end, we probed the sialidase activity of intact neuroblastoma
cells towards a soluble radiolabelled GD1a-neoganglioprotein
as an extracellular substrate that does not insert into mem-
branes.
2. Materials and methods
Lyso-ganglioside GD1a was obtained from Calbiochem (Bad So-
den, Germany), succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-
carboxylate (SMCC) and N-succinimidyl-S-acetylthioacetate (SATA)
were from Pierce (Rockford, IL, USA), BSA (fatty acid- and globulin-
free), vinblastine, heparin (sodium salt, high molecular weight, from
porcine intestinal mucosa), heparan sulfate (sodium salt, from bovine
intestinal mucosa), colominic acid and fetuin (from fetal calf serum)
were from Sigma (Munich, Germany). Chondroitin sulfate A (sodium
salt, from shark notochord) and chondroitin sulfate B (sodium salt,
from pig skin) were purchased from ICN (Eschwege, Germany). N-
Acetylneuraminic acid (NeuAc) and 2,3-dehydro-2-deoxy-N-acetyl-
neuraminic acid (NeuAc2en) were from Roche (Mannheim, Ger-
many).
For preparation of GD1a-neoganglioprotein, lyso-GD1a was
treated with SMCC producing maleimidyl-derivatized ganglioside,
which was subsequently coupled to SATA-reacted BSA. The whole
procedure was exactly as described by Mahoney and Schnaar [15].
For iodination, 20 Wg GD1a-neoganglioprotein was incubated at
room temperature for 15 min in 50 mM sodium phosphate, pH 7.4,
with 74 MBq carrier-free Na125I (Hartmann, Braunschweig, Ger-
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many). Labelled protein was separated from free iodine by gel ¢ltra-
tion on Sephadex G-25 (PD-10 column, Amersham Pharmacia, Frei-
burg, Germany). Speci¢c radioactivity of the labelled protein was 770
kBq/Wg.
Neuroblastoma cells (SK-N-MC) were seeded in 96-well tissue cul-
ture plates at an initial density of 10 000 cells per well and cultured for
5 days at 37‡C in Eagle’s minimal essential medium (Biochrom, Ber-
lin, Germany) supplemented with 10% fetal calf serum (PAA, Linz,
Austria), penicillin (100 IU/ml), streptomycin (100 Wg/ml) and non-
essential amino acids in an atmosphere of 95% air and 5% CO2. Then
5 kBq 125I-labelled GD1a-neoganglioprotein was included in the me-
dium and GM1-neoganglioprotein formed was determined after 4, 8,
12 or 16 h of incubation at 37 and 18‡C, respectively. To quantitate
the GM1-neoganglioprotein content of the medium, it was transferred
to 96-well Maxisorp plates (Nunc, Roskilde, Denmark) that had been
coated with 1 Wg cholera toxin B in 100 Wl 100 mM Na2CO3 bu¡er,
pH 9.6 for 12 h at 4‡C, blocked with 1% bovine serum albumin (BSA)
in phosphate-bu¡ered saline (PBS), and washed three times with PBS/
0.05% Tween 20. The plates were agitated in the cold room for 8 h on
a reciprocating shaker before the supernatants were removed, the
plates washed three times with 200 Wl PBS/Tween, and cholera toxin
B-bound radioactivity solubilized with 200 Wl 0.5 N NaOH and mea-
sured in a liquid scintillation counter with external standardization
(Canberra Packard TRICARB 2900, counting region 0^70 keV).
Conditioned medium was taken from cultures after 5 days and
transferred to empty 96-well plates and incubated with labelled
GD1a-neoganglioprotein as above.
Cellular protein was measured after removal of the medium and
two washes with PBS by solubilization of the cells with 20 Wl 0.2 N
NaOH and conducting the Lowry protein determination [16] directly
in the culture wells using a microtest plate reader (Anthos 2010).
Plasma membrane-bound ganglioside sialidase activity in neuro-
blastoma cell homogenates was assayed as described previously [6].
3. Results and discussion
Neoganglioproteins, such as lyso-GD1a-derivatized BSA,
are excellent tools for the characterization and identi¢cation
of ganglioside-recognizing proteins [15], because they circum-
vent experimental problems caused by the amphipathic nature
of gangliosides that result in their hydrophobic binding to and
spontaneous insertion into cell membranes. Although they
retain the lipid structure, the covalently bound gangliosides
are prevented from inserting into cell membranes, and so ap-
pear useful for detecting plasma membrane-bound ganglioside
sialidase activity of whole cells towards extracellularly pre-
sented substrate. The result of such an experiment is shown
in Fig. 1A, where GD1a-neoganglioprotein was included in
the culture medium of SK-N-MC neuroblastoma cells and
the product of the sialidase reaction, GM1-neoganglioprotein,
determined at various time points using cholera toxin B in a
solid phase assay. The amount of GM1-neoganglioprotein
increased in a time-dependent manner, indicating sialidase
activity towards substrate presented from outside of the en-
zyme’s membrane. Addition of the speci¢c sialidase inhibitor
NeuAc2en to the culture medium totally abolished the desia-
lylation reaction. Activity measurements in the conditioned
medium from neuroblastoma cultures excluded the possibility
that a soluble sialidase either originating from secretion [17]
or from the fetal calf serum present in the culture medium
might contribute to the observed neoganglioprotein desialya-
tion. The present novel methodology for the measurement of
ganglioside sialidase activity using a neoganglioprotein sub-
strate might also prove useful for other applications where
the use of detergents for substrate solubilization has to be
avoided, e.g., when intact cells or subcellular organelles are
to be used.
It was suggested that ganglioside substrates and the plasma
Fig. 1. A: Sialidase activity towards extracellular GD1a-neoganglioprotein: Neuroblastoma cells were grown in 96-well plates for 5 days. Then
the cells were incubated in the absence (b) or presence (E) of 250 WM NeuAc2en with 5 kBq of iodinated GD1a-neoganglioprotein for the in-
dicated time periods. Conditioned medium (P) of the cultures was likewise incubated with labelled GD1a-neoganglioprotein in 96-well plates.
B: E¡ect of vinblastine or ammonium chloride on desialylation of GD1a-neoganglioprotein: Sialidase activity towards extracellular GD1a-neo-
ganglioprotein was assayed in absence (b) or in presence of (7) 50 WM vinblastine or (O) 20 mM ammonium chloride. GM1-neogangliopro-
tein formed by sialidase action was determined by its binding to cholera toxin B subunit in solid phase assay as described in Section 2. Results
are the means of eight determinations, error bars representing S.E.M.
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membrane sialidase become internalized into some intracellu-
lar acidic compartment like endosomes for desialylation reac-
tion to occur [12]. This would require intracellular vesicle
transport and acidi¢cation of the compartment. However, vin-
blastine, a microtubule inhibitor, and ammonium chloride, a
neutralizer of acidic compartments [18] did not a¡ect GD1a-
neoganglioprotein desialylation (Fig. 1B). As a further test,
incubations were performed at 18‡C where no endocytotic
uptake of extracellular substrate can occur. Although reaction
velocity was lower, considerable GD1a-neoganglioprotein de-
sialylation at this temperature was observed (Fig. 2). The
reduction of the sialidase activity in comparison to incuba-
tions at 37‡C seems to be a direct e¡ect of the lowered tem-
perature on enzyme catalysis, as it was also observed when
cell homogenates were assayed in vitro for Triton-activated
plasma membrane sialidase activity towards ganglioside
GM3 (Fig. 3). Both observations, lack of inhibition by vin-
blastine or ammonia and sustained activity at 18‡C, favor
the supposition that the sialidase directly acts on the cell sur-
face rather than in secondarily formed intracellular vesicles.
This point of view is also supported by the fact that the neo-
ganglioprotein product is found in the extracellular space and
is not degraded by the endosomal/lysosomal pathway as
should be expected in the case of intravesicular action of the
sialidase.
In previous studies, the in£uence of various potential inhib-
itors on the plasma membrane sialidase had been determined
in detergent-activated neuroblastoma homogenates [8]. The
data shown in Fig. 4 indicate that the results now obtained
with the enzyme in its native environment closely correspond
to the results previously obtained in an arti¢cial system. In
particular, besides the speci¢c inhibitor NeuAc2en, the extra-
cellular matrix and cell surface constituent heparan sulfate, as
well as heparin, are potent inhibitors. The chondroitin sulfates
A and B, on the other hand, had only small e¡ects, and
NeuAc at 1 mM was not inhibitory.
The membrane-bound ganglioside sialidase puri¢ed from
human brain [9] or that present in plasma membranes of
SK-N-MC cells [7] did not desialylate non-lipid sialoglycocon-
jugates such as sialoglycoproteins, sialyloligosaccharides, or
polysialic acids, and it was anticipated that this also holds
true for the enzyme in situ. Indeed, we did not detect any
competitive e¡ect of 3P-sialyllactose, fetuin, or colominic
acid on the desialylation of GD1a-neoganglioprotein in the
cell cultures (Table 1), thus establishing the enzyme’s strict
ganglioside speci¢city also in its intact natural environment.
Our results con¢rm and extend previous observations by
Schengrund et al. of an ecto-sialidase in transformed hamster
cells [19].
The ¢nding that the cell surface sialidase can attack sub-
Fig. 2. Sialidase activity towards extracellular GD1a-neogangliopro-
tein at 18‡C. GD1a-neoganglioprotein desialylation was measured in
(b) absence or (E) presence of NeuAc2en and in (P) conditioned
medium of neuroblastoma cultures as described for Fig. 1, with the
exception that the incubation temperature was lowered from 37 to
18‡C. Results are the means of eight determinations, error bars rep-
resenting S.E.M.
Fig. 3. Temperature dependence of the plasma membrane ganglio-
side sialidase activity. Plasma membrane sialidase activity towards
tritium-labelled ganglioside GM3 was assayed in homogenates of
neuroblastoma cells after speci¢c activation with Triton X-100 at
the indicated incubation temperatures. Results are the means of
four determinations, error bars representing S.E.M.
Fig. 4. E¡ect of sialidase inhibitors on desialylation of GD1a-neo-
ganglioprotein. Neuroblastoma cells were grown in 96-well cell
plates for 5 days. Then cells were cultured in absence (control) or
presence of potential inhibitors with 5 kBq of iodinated GD1a-neo-
ganglioprotein for 16 h before GM1-neoganglioprotein product was
determined: NeuAc2en, 250 WM; NeuAc, 1 mM; H = 100 Wg/ml
heparin; HS = 100 Wg/ml heparan sulfate; CSA = 100 Wg/ml chon-
droitin sulfate A; CSB = 100 Wg/ml chondroitin sulfate B. Results
are the means of four determinations, error bars representing
S.E.M.
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strates beyond its own membrane might be of considerable
physiological importance. Sialidase-modulated changes in
the behavior of neuroblastoma cells such as growth inhibition
or di¡erentiation are observed at cell densities bringing about
direct intercellular contact [6,8]. Our present results point to
the possibility that the plasma membrane sialidase might be
able to desialylate gangliosides on the surface of adjacent
cells, thereby acting as some kind of sensor for cell contact.
Further investigations are to be conducted to prove this at-
tractive possibility.
Acknowledgements: We thank Cornelia Lehmann and Vera Schuh-
mann for expert technical assistance.
References
[1] Hakomori, S. and Igarashi, Y. (1995) J. Biochem. 118, 1091^
1103.
[2] Riboni, L., Viani, P., Bassi, R., Prinetti, A. and Tettamanti, G.
(1997) Prog. Lipid Res. 36, 153^195.
[3] Kopitz, J. (1997) Glycolipids: structure and functions, in: Gly-
cosciences: Status and Perspectives (Gabius H.J. and S., Eds.),
pp. 163^189, Chapman and Hall, London.
[4] Preti, A., Fiorilli, A., Lombardo, A., Caimi, L. and Tettamanti,
G. (1980) J. Neurochem. 35, 281^296.
[5] Scheel, G., Acevedo, E., Conzelmann, E., Nehrkorn, H. and
Sandho¡, K. (1982) Eur. J. Biochem. 127, 245^253.
[6] Kopitz, J., von Reitzenstein, C., Mu«hl, C. and Cantz, M. (1994)
Biochem. Biophys. Res. Commun. 199, 1188^1193.
[7] Kopitz, J., von Reitzenstein, C., Sinz, K. and Cantz, M. (1996)
Glycobiology 6, 367^376.
[8] Kopitz, J., Mu«hl, C., Ehemann, V., Lehmann, C. and Cantz, M.
(1997) Eur. J. Cell. Biol. 73, 1^9.
[9] Kopitz, J., Sinz, K., Brossmer, R. and Cantz, M. (1997) Eur. J.
Biochem. 248, 527^534.
[10] Hata, K., Wada, T., Hasegawa, A., Kiso, M. and Miyagi, T.
(1998) J. Biochem. Tokyo 123, 899^905.
[11] Wada, T., Yoshikawa, Y., Tokuyama, S., Kuwabara, M., Akita,
H. and Miyagi, T. (1999) Biochem. Biophys. Res. Commun. 261,
21^27.
[12] Miyagi, T., Wada, T., Iwamatsu, A., Hata, K., Yoshikawa, Y.,
Tokuyama, S. and Sawada, M. (1999) J. Biol. Chem. 274, 5004^
5011.
[13] Hasegawa, T., Yamaguchi, K., Wada, T., Takeda, A., Itoyama,
Y. and Miyagi, T. (2000) J. Biol. Chem. 275, 8007^8015.
[14] Monti, E., Bassi, M.T., Papini, N., Riboni, M., Manzoni, M.,
Venerando, B., Crozgi, G., Preti, A., Ballabio, A., Tettamanti, G.
and Borsani, G. (2000) Biochem. J. 349, 343^351.
[15] Mahoney, J.A. and Schnaar, R.L. (1994) Methods Enzymol. 242,
17^27.
[16] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J.
(1951) J. Biol. Chem. 193, 265^275.
[17] Usuki, S., Lyu, S.C. and Sweeley, C.C. (1988) J. Biol. Chem. 263,
6847^6853.
[18] Seglen, P.O. (1983) Methods Enzymol. 96, 737^764.
[19] Schengrund, C.L., Lausch, R.N. and Rosenberg, A. (1973)
J. Biol. Chem. 248, 4424^4428.
Table 1
E¡ect of potential non-lipid substrates on GD1a-neoganglioprotein
sialidase activity of cultured neuroblastoma cells
Compound GM1-neoganglioprotein formed
(dpm/Wg cellular protein)
Control 351 þ 46.8
10 mM NeuAc residues bound
to fetuin
361 þ 23.8
10 mM 3P-sialyllactose 357 þ 46.9
10 mM NeuAc residues bound
in colominic acid
347 þ 31
5 kBq iodinated GD1a-neoganglioprotein and potential competitive
substrates were included in the culture medium for 16 h before
formed GM1-neoganglioprotein was determined as described under
Section 2. Results are the means of four measurements þ S.E.M.
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